Abstract:Objective To study the clinical significance on the combined determination of serum N-terminal pro-B-type natriuretic peptide (NT-proBNP),heart-type fatty acid-binding protein(H-FABP)and cardiac troponin I(cTnI)in elder patients with severe heart failure (HF ).Methods The serum NT-proBNP,H-FABP and cTnI levels were determined in 31 2 elder patients with severe HF {main adverse cardiovascular event (MACE )group (1 94 cases ) [cardiogenic readmission group(1 1 0 cases)and death group(84 cases)]and no-MACE group(1 1 8 cases)}on admission, day 7,1 5,30 and 60 after treatment,76 elder patients with no-severe HF and 40 elder healthy subjects.The MACE were followed and observed for 1 80 d.The significance of NT-proBNP,H-FABP and cTnI for the diagnosis of severe HF and the prediction of death risk was analyzed by receiver operating characteristic(ROC)curve.Survival analysis was performed by Kaplan-Meier curve.Results The serum NT-proBNP,H-FABP and cTnI levels in elder patients with severe HF were significantly higher than those in elder patients with no-severe HF and healthy subjects (P<0.01 ),the positive rate of H-FABP in elder patients with no-severe HF was 47.1%,and the positive rate of cTnI was 4.5%.The serum NT-proBNP levels were positively correlated with the grade of New York Heart Association (NYHA)Ⅰ-Ⅳ(r=0.77,P<0.01 ).The ROC curve indicated that the optimal cut-off values of serum NT-proBNP,H-FABP and cTnI levels for diagnosis in elder patients with severe HF were 4 601 .50 ng/L,5.1 6 ng/L and 0.025 ng/mL,and the optimal cut-off values of serum NT-proBNP,H-FABP and cTnI levels for the death risk evaluation in elder patients with severe HF were 8 1 78.50 ng/L, 1 1 .77ng/L and 0.038ng/mL,respectively.The sensitivity of the combined determination was obviously better than those of the individual determinations (P<0.05 ).Before the treatment,the serum NT-proBNP levels in MACE group were significantly higher than those in no-MACE group(P<0.05),the serum H-FABP levels in death group were significantly higher than those in no-death group(P<0.05 ),and the serum cTnI levels in various prognosis groups had no statistical significance (P>0.05 ).The serum NT-proBNP,H-FABP and cTnI levels in no-MACE group on day 7 after treatment were significantly lower than those before the treatment (P<0.05 ).The decreasing rates of the 3 parameters were >50%,and the serum H-FABP level was lower than the normal reference value.The serum NT-proBNP,H-FABP and cTnI levels in the cardiogenic readmission group on day 1 5 after treatment were significantly lower than those before treatment (P<0.05),but the decreasing rates of the 3 parameters were <30%,and the serum H-FABP level was higher than the normal reference value.The serum NT-proBNP,H-FABP and cTnI levels in death group on day 7 and day 30 after treatment were significantly higher than those before treatment(P<0.05),and the serum cTnI levels were higher than the normal reference value.Kaplan-Meier survival curve showed that the survival rates of serum NT-proBNP,H-FABP and cTnI levels had significant difference (P <0.05 ).Conclusions There is an important clinical significance of the combined determination of serum NT-proBNP,H-FABP and cTnI levels for the diagnosis,prognosis,death risk evaluation and curative effect survey in elder patients with severe HF.

The value of diagnosis and prognosis diagnostic on heart failure patients by joint detection with CTnI, hs-CRP and NT-ProBNP

The Clinical Significance on the Combined Determination of NT-proBNP,H-FABP and Ctni in Elder Patients with Severe Heart Failure

Value of Serum N-terminal Pro-B-type Natriuretic Peptide for the Diagnosis and Prognosis Evaluation in Patients with Coronary Heart Disease

The Research of Joint Detection of C-Reactive Protein,Fibrinogen and N-terminal Pro-brain Natri-uretic Peptide in Patients with Chronic Atrial Fibrillation Complicated by Possible Heart Failure

Diagnostic Value of NT-proBNP Levels and Other Biochemical Indices for Cardiovascular Diseases by Receiver Operating Characteristic Curves

Relation between three biomarkers and prognosis of heart failure

Clinical value of N-terminal proBNP in diagnosis of left heart failure

Levels and clinical significance of serum NT-proBNP, UA and hs-CRP in chronic heart failure

Clinical study on relationship of hs-CRP level with presence and prognosis of cardiac dys-function in patients with type 2 diabetes after percutaneous coronary intervention

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and Glomerular Filtration Rate in Patients with Acute Heart Failure

Significance of NT-proBNP Level in Patients with Heart Failure after Interventional Treatment and Value Prediction on Myocardial Function

Value of BNP in Diagnosis of Heart Failure and Monitoring of Efficacy

The Effectiveness of NT-proBNP in Diagnosing Heart Failure

Clinical application and evaluation of N-terminal pro-Brain natriuretic peptide quantitative detection in heart failure laboratory diagnosis

Values of plasma N-terminal pro-B-type natriuretic peptide in severity assessment and prognostic prediction for chronic heart failure in the elderly

Relationship between N-terminal pro-brain natriuretic peptide and heart failure

The Value of Serum Free Triiodothyronine and BNP in Long Term Prognostic of Patients with Chronic Heart Failure

Clinical Value Analysis of Combined NT-pro BNP hs-CRP and D-D in Acute Myocardial Infarction

Prognostic Value of High-Sensitivity C-reactive Protein in Patients with Chronic Heart Failure.

Clinical Value of Combined Detection of CK-MB, MYO, Ctni and Plasma NT-proBNP in the Diagnosis of Acute Myocardial Infarction

The Application of N-terminal Pro-brain B-type Natriuretic Peptides in the Diagnosis of Elderly Patients with Chronic Heart Failure